Li et al. observed that suppressing MYH9 reduced the stemness, EMT, angiogenesis, metastasis, and tumorigenicity of EC cells, implying a pro-tumorigenic role for MYH9 in EC, closely linked to tumor stage (Li Q. et al., 2023). This evidence concerns the gene MYH9 and neoplasm.